Goldline Pharmaceutical
add_icon

Goldline Pharmaceutical

44.25
+1.14
(2.64%)
Market Cap
42.49 Cr
PE Ratio
-
Volume
2,73,000.00
Day High - Low
47.95 - 42.84
52W High-Low
60.00 - 41.41
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
42.49 Cr
EPS
5.97
PE Ratio
-
PB Ratio
2.05
Book Value
21.00
EBITDA
6.94
Dividend Yield
0.00 %
Industry
-
Sector
-
Return on Equity
27.37
Debt to Equity
1.22
Forecast For
Actual

Company News

View All News
Caret
positive
Goldline Pharmaceutical Limited reported a 45.2% rise in net profit to ₹411.71 lakh for FY26. Revenue from operations increased 11.2% to ₹3,119.76 lakh.
neutral
Goldline Pharmaceutical Limited will hold a board meeting on June 09, 2026, to consider audited financial results for the half-year and year ended March 31, 2026.
Growth Rate
Revenue Growth
11.03 %
Net Income Growth
41.43 %
Cash Flow Change
-20.55 %
ROE
19.21 %
ROCE
18.67 %
EBITDA Margin (Avg.)
6.97 %

Yearly Financial Results

Annual Financials
2023
2024
2025
2026
Revenue
20
24
28
31
Expenses
18
19
22
24
EBITDA
2
4
6
7
Operating Profit %
11 %
18 %
21 %
22 %
Depreciation
0
0
0
0
Interest
2
2
2
1
Profit Before Tax
0
3
4
5
Tax
0
1
1
1
Net Profit
0
2
3
4
EPS in ₹
0.43
3.01
4.11
5.97

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
19
23
26
29
Fixed Assets
3
3
3
3
Current Assets
17
20
23
26
Capital Work in Progress
0
0
0
0
Investments
0
0
0
6
Other Assets
17
20
23
0
Total Equity & Liabilities
19
23
26
29
Current Liabilities
9
10
12
12
Non Current Liabilities
5
5
4
3
Total Equity
6
8
10
14
Reserve & Surplus
2
4
2
6
Share Capital
4
4
9
9

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
-0
1
0
Investing Activities
-1
-1
0
Operating Activities
2
3
2
Financing Activities
-1
-1
-2

Share Holding

% Holding
Sept 2025
May 2026
Promoter
79.71 %
79.71 %
FIIs
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
Others
20.29 %
20.29 %
No of Share Holders
20
20

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
09 Jun 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Jun 2026 46.03 44.20

Technical Indicators

RSI(14)
Neutral
32.88
ATR(14)
Less Volatile
2.97
STOCH(9,6)
Oversold
19.27
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Uptrend And Accelerating
0.35
WillR(14)
Oversold
-83.61